Overview

To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture

Status:
Recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Crohn's disease (CD) with stenosis has limited therapeutic options and with high surgical rate. The present clinical trial aims to evaluate the efficacy and safety of rapamycin in the treatment of stricturing Crohn's Disease.
Phase:
N/A
Details
Lead Sponsor:
The Second Hospital of Nanjing Medical University
Collaborator:
Xijing Hospital of Digestive Diseases
Treatments:
Azathioprine
Everolimus
Infliximab
Prednisone
Sirolimus